| Current Price | $16.82 | Mkt Cap | $3.0B |
|---|---|---|---|
| Open | $16.99 | P/E Ratio | 0.00 |
| Prev. Close | $16.82 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $16.67 - $17.19 | Volume | 2,166,780 |
| 52-Wk Range | $3.30 - $17.74 | Avg. Daily Vol. | 3,016,557 |
A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.
| Current Price | $16.82 | Mkt Cap | $3.0B |
|---|---|---|---|
| Open | $16.99 | P/E Ratio | 0.00 |
| Prev. Close | $16.82 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $16.67 - $17.19 | Volume | 2,166,780 |
| 52-Wk Range | $3.30 - $17.74 | Avg. Daily Vol. | 3,016,557 |
The best Bull and Bear pitches based on recency and number of recommendations.
As I predicted, BioCryst still had a little life left which allowed me to escape my green thumb and flip turn into a red one. 33% jump today, and all because of this:BioCryst Pharmaceuticals, Inc. today announced that it received a preliminary… More
Read the most recent pitches from players about BCRX.
Recs
Paco57
(65.15)
Submitted: 7/22/2021 1:17:48 PM :
Start Price:
$17.18
NASDAQ:BCRX Score:
-2.99
I've been following this one since $4 a share.
Buy this one NOW before it blows up!!!
Recs
PensionExtender
(42.60)
Submitted: 6/30/2020 5:50:50 PM :
Start Price:
$4.90
NASDAQ:BCRX Score:
+201.56
COVID-19 biotech should continue to grow with oral delivery system of vaccine
Recs
mdriver78
(74.76)
Submitted: 5/8/2020 1:14:04 PM :
Start Price:
$4.36
NASDAQ:BCRX Score:
+239.70
Expecting positive sales of over $500 on Berotralstat approval. Plus early clinical data supports BCX9930 as oral monotherapy for complement-mediated diseases plus patient dosing underway in galidesivir trial in COVID-19 patients in Brazil. All sounds quite positive and worth a flyer.
Find the members with the highest scoring picks in BCRX.
cozynite (33.58) Score: +1,003.98
The Score Leader is the player with the highest score across all their picks in BCRX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| cozynite | 33.58 | 3/14/2013 |
|
5Y | $1.31 | +1,183.97% | +179.99% | +1,003.98 | 0 Comment | |
| MrTwo94 | 90.29 | 11/8/2012 |
|
1Y | $1.37 | +1,127.74% | +214.08% | +913.66 | 0 Comment | |
| jgrnot | 20.47 | 12/4/2012 |
|
5Y | $1.41 | +1,092.99% | +210.48% | +882.51 | 0 Comment | |
| Sytes | < 20 | 5/29/2013 |
|
3Y | $1.60 | +951.25% | +165.28% | +785.97 | 1 Comment | |
| bearonwallstreet | 56.92 | 5/16/2013 |
|
5Y | $1.70 | +889.41% | +164.71% | +724.71 | 0 Comment | |
| warrenout3 | 40.26 | 12/3/2012 |
|
5Y | $1.63 | +931.90% | +207.30% | +724.60 | 0 Comment | |
| portefeuille2 | 98.92 | 2/16/2016 |
|
5Y | $1.87 | +799.47% | +131.35% | +668.11 | 0 Comment | |
| Roger55125 | 27.80 | 4/24/2013 |
|
5Y | $1.80 | +834.44% | +178.04% | +656.40 | 0 Comment | |
| Bigsef77 | 70.92 |
|
|
5Y | $1.89 | +789.95% | +134.01% | +655.94 | 0 Comment | |
| portefeuille | 98.55 |
|
|
NS | $1.92 | +776.50% | +133.98% | +642.52 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
